Vor Biopharma (VOR) said Friday it expects to raise about $55.6 million in gross proceeds from a private placement of 55.9 million shares, and warrants for 69.8 million shares at a combined price of $0.99425 per share and warrant.
The company said the seven-year warrants, exercisable at $0.838 per share, could yield an additional $58.5 million if exercised. The financing, led by new investor Reid Hoffman and existing shareholder RA Capital Management, includes provisions for each to gain representation on the board, Vor said.
Vor Bio said it plans to use the net proceeds from the placement, slated to close around Dec. 30, for clinical and preclinical development and corporate purposes.
The company also said it expects to provide updates on trials involving its VBP301 and VBP101 pipeline candidates in 2025.
Shares of the company were up more than 16% ahead of Friday's opening bell.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。